A new long-lasting non-hormonal contraceptive device for women
Official title: A novel, non-hormonal, long-acting female contraceptive device
Funded at Venova Technologies, INC. · NIH-11006653 · Data updated 2026-11-12
This study is testing a new, long-lasting birth control device that doesn't use hormones or cause side effects, aimed at helping women who are looking for a better alternative to current hormonal options.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Venova Technologies, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | September 13, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $383,114 |
| NIH project number | 1R43HD116640-01 |
| Project ID | NIH-11006653 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women seeking effective contraception without hormonal side effects.
✕Less likely to help
Patients who are already satisfied with their current hormonal contraceptive methods may not benefit from this research.
What this research studies
This research focuses on developing an innovative non-hormonal contraceptive device that is designed to be long-acting and free from side effects. The project aims to advance a patent-pending technology through biocompatibility testing and clinical trials, addressing the unmet needs of women who are dissatisfied with current hormonal contraceptive options. By exploring a new approach to contraception, this research seeks to provide a viable alternative that does not interfere with menstrual cycles or cause unwanted side effects.
Why it matters
Potential benefit: If successful, this research could provide women with a reliable, non-hormonal contraceptive option that minimizes side effects and meets their preferences.
How similar studies have gone: While there have been successful developments in hormonal contraceptives, this approach to a non-hormonal long-acting device is relatively novel and has not been extensively tested.
Where this research is happening
-
Venova Technologies, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Man, Emily — Venova Technologies, INC.
- Study coordinator: Man, Emily
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
HIV in Women: How the virus hides and the immune system changes across life stages
This project looks at how HIV behaves differently in people from puberty through menopause, focusing on how hormones like estrogen may affect HIV persistence and immune responses.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Computational modeling of female hormone balance and drug responses
A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.
-
How PrEP Drugs Affect HIV Risk in Women and Reproductive Health
This project looks at how PrEP medicines work for women, and whether they influence pregnancy-related processes in the uterus.
-
How female eggs throw away most chromosomes during meiosis
A scientist at UC Davis is studying why only a quarter of chromosomes go into the egg during female reproductive cell division and how errors in this process can cause miscarriage or birth defects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.